Skip to main content
ImmuneCited

Vitamin E için Immune Aging (Immunosenescence)

B

Clinical trials in elderly populations demonstrate vitamin E supplementation at 200 IU/day may enhance delayed-type hypersensitivity (DTH) skin test response and antibody production. Recognized as one of the most effective single nutrients for modulating immune function in older adults.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002De\u0026condition\u003Dimmunosenescence'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Sonuç

Clinical trials in elderly populations demonstrate vitamin E supplementation at 200 IU/day may enhance delayed-type hypersensitivity (DTH) skin test response and antibody production. Recognized as one of the most effective single nutrients for modulating immune function in older adults.

Key Study Findings

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD Etki: None None

Popülasyon: Children with inflammatory bowel disease (review)

Observational Study n=2065
Cytomegalovirus (CMV), oxidative stress, and inflammation: implications for immunosenescence and age-related diseases in the MARK-AGE …
Dose: None vs: None Outcome: CMV IgG association with oxidative stress markers Etki: None None

Popülasyon: Age-stratified general population (MARK-AGE RASIG cohort)

In Vitro
Anti-Hair Loss Potential of Perilla Seed Extracts: In Vitro Molecular Insights from Supercritical Fluid Extraction.
Dose: None vs: Untreated HFDPCs; finasteride, dutasteride, minoxidil Outcome: SRD5A1-3 and TGF-beta1 expression Etki: HFDPC proliferation 139.4+/-1.1% at 72h p<0.05

Popülasyon: Human hair follicle dermal papilla cells (in vitro)

Review
Nutrition, Immunosenescence, and Infectious Disease: An Overview of the Scientific Evidence on Micronutrients and on …
Dose: None vs: None Outcome: None Etki: None None

Popülasyon: Elderly with immunosenescence

Other
The impact of vitamin E and/or selenium dietary supplementation on growth parameters and expression levels …
Dose: 100 mg vs: control Outcome: None Etki: or 1 None

Popülasyon: None

Review n=26282 988 weeks
Inadequacy of Immune Health Nutrients: Intakes in US Adults, the 2005-2016 NHANES.
Dose: 45% vs: None Outcome: None Etki: None None

Popülasyon: None

Key Statistics

5

Çalışmalar

600

Katılımcılar

Positive

B

Derece

Referenced Papers

World journal of … 2015 62 atıf
Annual review of … 2014 9 atıf
Aging and disease 2012 209 atıf
Journal of comparative … 2010 17 atıf
The British journal … 2002 358 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
15 mg/day (22.4 IU)
immunesupportelderly:
200 IU/day

Üst sınır: 1,000 mg/day (1,500 IU natural, 1,100 IU synthetic)

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Neutral --
None -- Negative 2065
None -- Positive --
None -- Mixed --
100 mg -- Positive --
45% 988 weeks Positive 26282
500 mg 12 weeks Mixed --
None -- Mixed --

En iyi alım zamanı: With meals containing fat

Safety & Side Effects

Bildirilen Yan Etkiler

  • Increased bleeding risk at high doses (>400 IU/day)
  • Nausea and gastrointestinal distress
  • Fatigue and muscle weakness at very high doses
  • Potential increased mortality risk at chronic high doses (meta-analysis finding, debated)

Bilinen Etkileşimler

  • Anticoagulants and antiplatelet drugs (increased bleeding risk)
  • Statins (may reduce statin effectiveness)
  • Chemotherapy agents (may interfere with oxidative mechanisms)
  • Vitamin K (high-dose vitamin E may antagonize vitamin K)

Tolere edilebilir üst alım: 1,000 mg/day (1,500 IU natural, 1,100 IU synthetic)

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Vitamin E help with Immune Aging (Immunosenescence)?
Based on 5 studies with 600 participants, there is moderate evidence from clinical studies that Vitamin E may support Immune Aging (Immunosenescence) management. Our evidence grade is B (Good Evidence).
How much Vitamin E should I take for Immune Aging (Immunosenescence)?
Studies have used various dosages. A commonly studied range is 15 mg/day (22.4 IU). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin E?
Reported side effects may include Increased bleeding risk at high doses (>400 IU/day), Nausea and gastrointestinal distress, Fatigue and muscle weakness at very high doses, Potential increased mortality risk at chronic high doses (meta-analysis finding, debated). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin E and Immune Aging (Immunosenescence)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 5 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

Related Evidence

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.